Overview
Pawel Muranski, MD, trained as a Hematologist and Oncologist at the Hematology Branch of the National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH) in Bethesda, Maryland where he subsequently worked as a faculty in the Stem Cell Allogeneic Transplantation Section. He joined Columbia University in 2017 as the Director of Cellular Immunotherapy. Dr. Muranski specializes in bone marrow transplant (BMT).
Areas of Expertise / Conditions Treated
- Bone Marrow Transplantation
- Leukemia
- Lymphoma
Academic Appointments
- Assistant Professor of Medicine at CUMC
Administrative Titles
- Director of Cellular Immunotherapy Laboratory
- Principal Investigator at the Columbia Center for Translational Immunology (CCTI)
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
Gender
- Male
Schedule an Appointment
Phone Appointments
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Location(s)
Insurance Accepted
Aetna
- Aetna Signature Administrators
- EPO
- HMO
- Medicare Managed Care
- NY Signature
- POS
- PPO
- Student Health
Affinity Health Plan
- Essential Plan
- Medicaid Managed Care
Amida Care
- Special Needs
Cigna
- EPO
- Great West (National)
- HMO
- Medicare Managed Care
- POS
- PPO
Emblem/GHI
- Medicare Managed Care
- PPO
Emblem/HIP
- ConnectiCare
- EPO
- Essential Plan
- HMO
- Medicaid Managed Care
- Medicare Managed Care
- POS
- PPO
- Select Care (Exchange)
- Vytra
Empire Blue Cross/Blue Shield
- EPO
- HMO
- Medicare Managed Care
- PPO
Empire Blue Cross Blue Shield HealthPlus
- Child/Family Health Plus
- Essential Plan
- Medicaid Managed Care
Fidelis Care
- Child/Family Health Plus
- Essential Plan
- Medicaid Managed Care
- Medicare Managed Care
Healthfirst
- Child/Family Health Plus
- Leaf (Exchange)
- Medicaid Managed Care
- Medicare Managed Care
Local 1199
- Local 1199
- NYP Employee Plan
MagnaCare (National)
- MagnaCare
Medicare
- Railroad
- Traditional Medicare
Multiplan
- Multiplan
MVP Health Care
- Child/Family Health Plus
- Essential Plan
- HMO
- Medicaid Managed Care
RiverSpring
- Special Needs
UnitedHealthcare
- Compass (Exchange)
- Empire Plan
- HMO
- Medicaid (Community Plan)
- Medicare Managed Care
- Oxford Freedom
- Oxford HMO
- Oxford Liberty
- POS
- PPO
VNSNY CHOICE
- Medicare Managed Care
- SelectHealth
- Special Needs
WellCare
- Medicaid Managed Care
- Medicare Managed Care
World Trade Center Health Plan
- World Trade Center Health Plan
Credentials & Experience
Education & Training
- MD, Medical University of Warsaw, Poland
- Residency: AMITA Health / Saint Francis Hospital, Evanston, Illinois
- Fellowship: National Institutes of Health (NIH), Bethesda, Maryland,
- Fellowship: National Cancer Institute (NCI), Bethesda, MD
Committees, Societies, Councils
- Member, Herbert Irving Comprehensive Cancer Center
Board Certifications
- Internal Medicine
- Hematology
Honors & Awards
- 2025: Agilent Research Catalyst (ARC) Award
Research
At NHLBI, Dr. Muranski has conducted studies on using T cells for prevention and treatment of common viral infections affecting bone marrow transplant recipients. He has also developed first-in-human study of adoptive immunotherapy for patients with JC virus-associated Progressive Multifocal Leukoencephalopathy (PML). In addition, he has completed a research fellowship in cancer immunology and immunotherapy at the Surgery Branch, National Cancer Institute, NIH.
He is a principal investigator at the Columbia Center for Translational Immunology and a member of the Herbert Irving Comprehensive Cancer Center. His laboratory focuses on developing potent T lymphocytes for adoptive immunotherapy of viral infections and cancer.
Research Interests
- Cancer
- Cellular Immunotherapy
- Immunology
- Immunotherapy
- Progressive Multifocal Leukoencephalopathy (PML)
- T Cells
- Transplant Immunology
- Viral Infections